PATENT CLAIM ANALYSIS

Application Number: 16371779
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-07
Patent Classification: ["514", "565000"]

Abstract:
Compositions for neuroprotection and treatment of neurodegeneration and methods of administering same. In particular, the present invention relates to compositions and methods for preventing or reducing neurodegeneration, such as neurodegeneration caused by Huntington's disease, including administering a daily dose of a composition including an effective amount of creatine hydrochloride to a patient in need thereof. The methods of the present invention allow for lower dosages of supplementation as compared to creatine monohydrate while retaining all of the desired biological effects of creatine supplementation.

Claim (Index 7):
The method of  claim 1 , wherein the composition further comprises creatinine, creatine monohydrate, creatine ester, or combinations thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 100.0
- Lexical Diversity: 1.57895
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15133501', '15353347', '12756686', '12942929', '15082207']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7421691427926833
- 35 USC 102 Novelty (BERT): 0.5570498578958655
- Combined Prediction Score: 0.7236572143030016
- Mean Citation Score: 227.445654
- Max Citation Score: 435.84625
- Similarity Product: 303.74733499079935

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test